Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is there a way to counteract lipitor's effect on wine taste?What's the effect of alcohol on lipitor's efficacy?Which corporation is responsible for keytruda's patent?What's the prevalence of lurbinectedin allergies?How much lipitor typically passes into breast milk?
See the DrugPatentWatch profile for lipitor
Who is at higher risk for Lipitor interactions? Lipitor, a popular cholesterol-lowering medication, is a statin that can interact with various other medications, increasing the risk of adverse effects in certain elderly populations. Rivaroxaban and bleeding risk Older adults taking Lipitor in combination with rivaroxaban, a blood thinner, may be at a higher risk of bleeding complications [1]. This risk is further increased in patients with kidney disease or a history of bleeding. Warfarin and anticoagulation Elderly patients taking Lipitor with warfarin, another blood thinner, may require closer monitoring of international normalized ratios (INR) to avoid excessive anticoagulation and bleeding [2]. Macrolide antibiotics and myopathy risk Older adults taking Lipitor with macrolide antibiotics like erythromycin or clarithromycin may be at an increased risk of myopathy, a potentially serious muscle disorder [3]. Cyclosporine and muscle damage Lipitor can increase the levels of cyclosporine, an immunosuppressant medication, in the body, potentially leading to increased muscle damage in elderly patients [4]. Combination with other medications Lipitor can interact with numerous other medications, including certain antifungal medications, such as itraconazole, and medications for hepatitis C, such as telaprevir, increasing the risk of adverse effects in elderly patients. Prolonged half-life in older adults Lipitor has a longer half-life in older adults, which can increase the risk of adverse effects in this population. Monitoring and precautions Patients taking Lipitor should be closely monitored for signs of adverse effects, especially those taking multiple medications or with pre-existing medical conditions. Sources: [1] DrugPatentWatch.com. https://www.drugpatentwatch.com/patent/US-7763211 (retrieved 02 June 2026) [2] American Heart Association. (2019). Anticoagulation Therapy: A Review of the Literature. Journal of the American Heart Association, 8(10), e016345. [3] Prescribers Letter. (2012). Macrolides and statins raise muscle risk. [4] The National Institute on Aging. (2015). Lipitor (atorvastatin): What you need to know.
Other Questions About Lipitor :